Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction

Experimental Cell Research

Volumn 319, Issue 15, 2013, Pages 2350-2359

  Chrzanowska Wodnicka, Magdalena ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Cerebral cavernous malformations; Contractility; Endothelial junctions; Vasculogenesis

Indexed keywords

AFADIN; BETA1 INTEGRIN; CYCLIC AMP; FIBROBLAST GROWTH FACTOR 2; INTEGRIN; PROTEIN; RAP1 PROTEIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLEEDING; BLOOD VESSEL FUNCTION; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR PARAMETERS; CAVERNOUS HEMANGIOMA; CELL FUNCTION; CELL JUNCTION; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM; GENETIC MODEL; HEMOSTASIS; KNOCKOUT MOUSE; LYMPH VESSEL; MOLECULAR INTERACTION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; THROMBOCYTE FUNCTION; VASCULAR DISEASE; VASCULAR INTEGRITY; ZEBRA FISH;

DANIO RERIO; MUS;

EID: 84883210190     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.07.022     Document Type: Review

References (96)

1. Frische E.W., Zwartkruis F.J.T. Rap1, a mercenary among the Ras-like GTPases. Dev. Biol. 2010, 340:1-9.
2. Lakshmikanthan S., Sobczak M., Chun C., Henschel A., Dargatz J., Ramchandran R., Chrzanowska-Wodnicka M. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin (alpha)v(beta)3. Blood 2011, 118:2015-2026.
3. Chrzanowska-Wodnicka M., Smyth S.S., Schoenwaelder S.M., Fischer T.H., White G.C. Rap1b is required for normal platelet function and hemostasis in mice. J. Clin. Invest. 2005, 115. (2296-2296).
4. Li Y., Yan J., De P., Chang H.-C., Yamauchi A., Christopherson K.W., Paranavitana N.C., Peng X., Kim C., Munugulavadla V., Kapur R., Chen H., Shou W., Stone J.C., Kaplan M.H., Dinauer M.C., Durden D.L., Quilliam L.A., Mice Have Rap1a Null Altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J. Immunol. 2007, 179:8322-8331.
5. Duchniewicz M., Zemojtel T., Kolanczyk M., Grossmann S., Scheele J.S., Zwartkruis F.J.T. Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Mol. Cell. Biol. 2006, 26:643-653.
6. Yan J., Li F., Ingram D.A., Quilliam L.A. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol. Cell. Biol. 2008, 28:5803-5810.
7. 3. Blood 2011, 118:2015-2026.
8. Takakura N., Huang X.-L., Naruse T., Hamaguchi I., Dumont D.J., Yancopoulos G.D., Suda T. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 1998, 9:677-686.
9. Gore A.V., Lampugnani M.G., Dye L., Dejana E., Weinstein B.M. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis. Model. Mech. 2008, 1:275-281.
10. Liu J.J., Stockton R.A., Gingras A.R., Ablooglu A.J., Han J., Bobkov A.A., Ginsberg M.H. A mechanism of Rap1-induced stabilization of endothelial cell-cell junctions. Mol. Biol. Cell. 2011, 22:2509-2519.
11. Gore A.V., Lampugnani M.G., Dye L., Dejana E., Weinstein B.M. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. DMM Dis. Model. Mech. 2008, 1:275-281.
12. Pannekoek W.J., Kooistra M.R.H., Zwartkruis F.J.T., Bos J.L. Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim. Et Biophys. Acta-Biomembranes 1788, 2009:790-796.
13. Boettner B., Van Aelst L. Control of cell adhesion dynamics by Rap1 signaling. Curr. Opin. Cell. Biol. 2009, 21:684-693.
14. Liao Y., Kariya K.-i., Hu C.-D., Shibatohge M., Goshima M., Okada T., Watari Y., Gao X., Jin T.-G., Yamawaki-Kataoka Y., Kataoka T. RA-GEF, a novel Rap1A guanine nucleotide exchange factor containing a Ras/Rap1A-associating domain, is conserved between nematode and humans. J. Biol. Chem. 1999, 274:37815-37820.
15. Liao Y., Satoh T., Gao X., Jin T.G., Hu C.D., Kataoka T. RA-GEF-1, a guanine nucleotide exchange factor for Rap1, is activated by translocation induced by association with Rap1·GTP and enhances Rap1-dependent B-Raf activation. J Biol Chem. 2001, 276:28478-28483.
16. Wei P., Satoh T., Edamatsu H., Aiba A., Setsu T., Terashima T., Kitazawa S., Nakao K., Yoshikawa Y., Tamada M., Kataoka T. Defective vascular morphogenesis and mid-gestation in mice lacking RA-GEF-1. Biochem. Biophys. Res. Commun. 2007, 363:106-112.
17. Yang J.T., Rayburn H., Hynes R.O. Cell adhesion events mediated by [alpha] 4 integrins are essential in placental and cardiac development. Development 1995, 121:549-560.
18. Kwee L., Baldwin H.S., Shen H.M., Stewart C.L., Buck C., Buck C.A., Labow M.A. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 1995, 121:489-503.
19. Kanemura H., Satoh T., Bilasy S.E., Ueda S., Hirashima M., Kataoka T. Impaired vascular development in the yolk sac and allantois in mice lacking RA-GEF-1. Biochem. Biophys. Res. Commun. 2009, 387:754-759.
20. Suzuki K., Takahashi S., Haramoto Y., Onuma Y., Nagamine K., Okabayashi K., Hashizume K., Iwanaka T., Asashima M. XRASGRP2 is essential for blood vessel formation during Xenopus development. Int. J. Dev. Biol. 2010, 54:609-615.
21. Takino J., Nagamine K., Hori T. Ras guanyl nucleotide releasing protein 2 affects cell viability and cell-matrix adhesion in ECV304 endothelial cells. Cell Adhes. Migr. 2013, 7.
22. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., Takahashi H. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 1995, 15:6746-6753.
23. Ohba Y., Ikuta K., Ogura A., Matsuda J., Mochizuki N., Nagashima K., Kurokawa K., Mayer B.J., Maki K., Miyazaki J.I., Matsuda M. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 2001, 20:3333-3341.
24. Voss A.K., Gruss P., Thomas T. The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation. Development 2003, 130:355-367.
25. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
26. Chrzanowska-Wodnicka M., Kraus A.E., Gale D., White G.C., Vansluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008, 111:2647-2656.
27. Carmona G., G öttig S., Orlandi A., Scheele J., Böuerle T., Jugold M., Kiessling F., Henschler R., Zeiher A.M., Dimmeler S., Chavakis E. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 2009, 113:488-497.
28. Nasevicius A., Larson J., Ekker S.C. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 2000, 17:294-301.
29. Chrzanowska-Wodnicka M. Regulation of angiogenesis by a small GTPase Rap1. Vascul. Pharmacol. 2010, 53:1-10.
30. Chen Y.H., Yu M., Podd A., Wen R., Chrzanowska-Wodnicka M., White G.C., Wang D. A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood 2008, 111:4627-4636.
31. Chu H., Awasthi A., White G.C., Chrzanowska-Wodnicka M., Malarkannan S. Rap1b regulates B cell development, Homing, and T cell-dependent humoral immunity. J. Immunol. 2008, 181:3373-3383.
32. Takai Y., Ikeda W., Ogita H., Rikitake Y. The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu. Rev. Cell Dev. Biol. 2008, 24:309-342.
33. Boettner B., Govek E.-E., Cross J., Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc. Natl. Acad. Sci. U. S. A 2000, 97:9064-9069.
34. Tawa H., Rikitake Y., Takahashi M., Amano H., Miyata M., Satomi-Kobayashi S., Kinugasa M., Nagamatsu Y., Majima T., Ogita H., Miyoshi J., Hirata K.-i., Takai Y. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. Circ. Res. 2010, 106:1731-1742.
35. Revencu N., Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 2006, 43:716-721.
36. Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 1999, 23:189-193.
37. Sahoo T., Johnson E.W., Thomas J.W., Kuehl P.M., Jones T.L., Dokken C.G., Touchman J.W., Gallione C.J., Lee-Lin S.Q., Kosofsky B., Kurth J.H., Louis D.N., Mettler G., Morrison L., Gil-Nagel A., Rich S.S., Zabramski J.M., Boguski M.S., Green E.D., Marchuk D.A. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 1999, 8:2325-2333.
38. Liquori C.L. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 2003, 73:1459-1464.
39. Bergametti F. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2005, 76:42-51.
40. Serebriiskii I., Estojak J., Sonoda G., Testa J.R., Golemis E.A. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 1997, 15:1043-1049.
41. Guzeloglu-Kayisli O., Amankulor N.M., Voorhees J., Luleci G., Lifton R.P., Gunel M. KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes and pyramidal cells of the adult human cerebral cortex. Neurosurgery 2004, 54:943-949.
42. Uhlik M.T., Abell A.N., Johnson N.L., Sun W.Y., Cuevas B.D., Lobel-Rice K.E., Horne E.A., Dell'Acqua M.L., Johnson G.L. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell. Biol. 2003, 5:1104-1110.
43. Mably J.D., Chuang L.P., Serluca F.C., Mohideen M.A.P.K., Chen J.N., Fishman M.C. Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 2006, 133:3139-3146.
44. Hogan B.M., Bussmann J., Wolburg H., Schulte-Merker S. Ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 2008, 17:2424-2432.
45. Whitehead K.J., Plummer N.W., Adams J.A., Marchuk D.A., Li D.Y. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 2004, 131:1437-1448.
46. Denier C., Gasc J.M., Chapon F., Domenga V., Lescoat C., Joutel A., Tournier-Lasserve E. Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech. Dev. 2002, 117:363-367.
47. Plummer N.W., Squire T.L., Srinivasan S., Huang E., Zawistowski J.S., Matsunami H., Hale L.P., Marchuk D.A. Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm. Genome 2006, 17:119-128.
48. Plummer N.W., Gallione C.J., Srinivasan S., Zawistowski J.S., Louis D.N., Marchuk D.A. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol. 2004, 165:1509-1518.
49. Cunningham K., Uchida Y., O'Donnell E., Claudio E., Li W.L., Soneji K., Wang H.S., Mukouyama Y.S., Siebenlist U. Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. Hum. Mol. Genet. 2011, 20:3198-3206.
50. Hynes R.O. Cell-matrix adhesion in vascular development. J. Thromb. Haemostasis 2007, 5:32-40.
51. Robinson S.D., Hodivala-Dilke K.M. The role of β3-integrins in tumor angiogenesis: Context is everything. Curr. Opin. Cell. Biol. 2011, 23:630-637.
52. 3 and VEGFR2 in angiogenesis. Angiogenesis 2009, 12:177-185.
53. West X.Z., Meller N., Malinin N.L., Deshmukh L., Meller J., Mahabeleshwar G.H., Weber M.E., Kerr B.A., Vinogradova O., Byzova T.V., Integrin β 3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS ONE 2012, 7.
54. Deshmukh L., Meller N., Alder N., Byzova T., Vinogradova O. Tyrosine phosphorylation as a conformational switch: a case study of integrin β 3 cytoplasmic tail. J. Biol. Chem. 2011, 286:40943-40953.
55. Nagy J.A., Benjamin L., Zeng H.Y., Dvorak A.M., Dvorak H.F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008, 11:109-119.
56. Fukuhara S. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 2005, 25:136-146.
57. Cullere X., Shaw S.K., Andersson L., Hirahashi J., Luscinskas F.W., Mayadas T.N. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 2005, 105:1950-1955.
58. Wittchen E.S., Worthylake R.A., Kelly P., Casey P.J., Quilliam L.A., Burridge K. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J. Biol. Chem. 2005, 280:11675-11682.
59. Adamson R.H., Ly J.C., Sarai R.K., Lenz J.F., Altangerel A., Drenckhahn D., Curry F.E. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1188-1196.
60. Birukova A.A., Fu P., Xing J., Birukov K.G. Rap1 mediates protective effects of iloprost against ventilator-induced lung injury. J. Appl. Physiol. 2009, 107:1900-1910.
61. ® 1442 targets the cAMP/Rap1 pathway. J. Mol. Cell. Cardiol. 2012, 52:196-205.
62. Birukova A.A., Zebda N., Fu P., Poroyko V., Cokic I., Birukov K.G. Association between adherens junctions and tight junctions via rap1 promotes barrier protective effects of oxidized phospholipids. J. Cell. Physiol. 2011, 226:2052-2062.
63. Birukova A.A., Tian Y., Dubrovskyi O., Zebda N., Sarich N., Tian X., Wang Y., Birukov K.G. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J. Cell. Physiol. 2012, 227:3405-3416.
64. Zawistowski J.S. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 2005, 14:2521-2531.
65. Zawistowski J.S., Serebriiskii I.G., Lee M.F., Golemis E.A., Marchuk D.A. KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum. Mol. Genet. 2002, 11:389-396.
66. Zhang J., Clatterbuck R.E., Rigamonti D., Chang D.D., Dietz H.C. Interaction between krit1 and icap1 alpha infers perturbation of integrin beta 1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum. Mol. Genet. 2001, 10:2953-2960.
67. Liu W., Draheim K.M., Zhang R., Calderwood D.A., Boggon T.J. Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol. Cell. 2013, 49:719-729.
68. Wohlgemuth S., Kiel C., Kramer A., Serrano L., Wittinghofer F., Herrmann C. Recognizing and defining true Ras binding domains I: biochemical analysis. J. Mol. Biol. 2005, 348:741-758.
69. Béraud-Dufour S., Gautier R., Albiges-Rizo C., Chardin P., Faurobert E. Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J. 2007, 274:5518-5532.
70. Glading A., Han J., Stockton R.A., Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 2007, 179:247-254.
71. Li X., Zhang R., Draheim K.M., Liu W., Calderwood D.A., Boggon T.J. Structural basis for small G protein effector interaction of ras-related protein 1 (Rap1) and adaptor protein krev interaction trapped 1 (KRIT1). J. Biol. Chem. 2012, 287:22317-22327.
72. Francalanci F., Avolio M., De Luca E., Longo D., Menchise V., Guazzi P., Sgrò F., Marino M., Goitre L., Balzac F., Trabalzini L., Retta S.F. Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp. Cell. Res. 2009, 315:285-303.
73. Gunel M., Laurans M.S.H., Shin D., DiLuna M.L., Voorhees J., Choate K., Nelson-Williams C., Lifton R.P. KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10677-10682.
74. Kleaveland B., Zheng X., Liu J.J., Blum Y., Tung J.J., Zou Z., Chen M., Guo L., Lu M.-m., Zhou D., Kitajewski J., Affolter M., Ginsberg M.H., Kahn M.L. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 2009, 15:169-176.
75. Stockton R.A., Shenkar R., Awad I.A., Ginsberg M.H. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 2010, 207:881-896.
76. Seker A. Expression of integrins in cerebral arteriovenous and cavernous malformations. Neurosurgery 2006, 58:159-168.
77. Labauge P., Denier C., Bergametti F., Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007, 6:237-244.
78. Guazzi P., Goitre L., Ferro E., Cutano V., Martino C., Trabalzini L., Retta S.F. Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. PLoS ONE 2012, 7.
79. Wüstehube J., Bartol A., Liebler S.S., Brütsch R., Zhu Y., Felbor U., Sure U., Augustin H.G., Fischer A. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12640-12645.
80. Lampugnani M.G., Orsenigo F., Rudini N., Maddaluno L., Boulday G., Chapon F., Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell. Sci. 2010, 123:1073-1080.
81. Laurent A.C., Breckler M., Berthouze M., Lezoualc'h F. Role of Epac in brain and heart. Biochem. Soc. Trans. 2012, 40:51-57.
82. Somekawa S., Fukuhara S., Nakaoka Y., Fujita H., Saito Y., Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ. Res. 2005, 97:655-662.
83. Oestreich E.A., Wang H.A., Malik S., Kaproth-Joslin K.A., Blaxall B.C., Kelley G.G., Dirksen R.T., Smrcka A.V. Epac-mediated activation of phospholipase C epsilon plays a critical role in 6-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. J. Biol. Chem. 2007, 282:5488-5495.
84. Morel E., Marcantoni A., Gastineau M., Birkedal R., Rochais F., Garnier A., Lompre A.-M., Vandecasteele G., Lezoualc'h F. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ. Res. 2005, 97:1296-1304.
85. Metrich M., Lucas A., Gastineau M., Samuel J.-L., Heymes C., Morel E., Lezoualc'h F. Epac mediates {beta}-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ. Res. CIRCRESAHA 2008, 107:164947.
86. Métrich M., Laurent A.C., Breckler M., Duquesnes N., Hmitou I., Courillau D., Blondeau J.P., Crozatier B., Lezoualc'h F., Morel E. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell. Signal. 2010, 22:1459-1468.
87. Matsui T., Amano M., Yamamoto T., Chihara K., Nakafuku M., Ito M., Nakano T., Okawa K., Iwamatsu A., Kaibuchi K. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996, 15:2208-2216.
88. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
89. Chrzanowska-Wodnicka M., Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell. Biol. 1996, 133:1403-1415.
90. Somlyo A.P., Somlyo A.V. Ca 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 2003, 83:1325-1358.
91. Puetz S., Lubomirov L.T., Pfitzer G. Regulation of smooth muscle contraction by small GTPases. Physiology 2009, 24:342-356.
92. Zieba B.J., Artamonov M.V., Jin L., Momotani K., Ho R., Franke A.S., Neppl R.L., Stevenson A.S., Khromov A.S., Chrzanowska-Wodnicka M., Somlyo A.V. The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity. J. Biol. Chem. 2011, 286:16681-16692.
93. Ikeda W., Nakanishi H., Miyoshi J., Mandai K., Ishizaki H., Tanaka M., Togawa A., Takahashi K., Nishioka H., Yoshida H., Mizoguchi A., Nishikawa S.-i., Takai Y. Afadin: a key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J. Cell. Biol. 1999, 146:1117-1132.
94. Whitehead K.J., Chan A.C., Navankasattusas S., Koh W., London N.R., Ling J., Mayo A.H., Drakos S.G., Marchuk D.A., Davis G.E., Li D.Y. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 2009, 15:177-184.
95. Boulday G., Blécon A., Petit N., Chareyre F., Garcia L.A., Niwa-Kawakita M., Giovannini M., Tournier-Lasserve E. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: Implications for human cerebral cavernous malformations. DMM Dis. Model. Mech. 2009, 2:168-177.
96. Boulday G., Rudini N., Maddaluno L., Blécon A., Arnould M., Gaudric A., Chapon F., Adams R.H., Dejana E., Tournier-Lasserve E. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 2011, 208:1835-1847.